• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
SUN Jialin, PANG Lei, WANG Shuai, MENG Xiansheng, BAO Yongrui. Establishment of myocardial ischemia-reperfusion injury model based on microfluidic chip[J]. Journal of China Pharmaceutical University, 2014, 45(6): 710-714. DOI: 10.11665/j.issn.1000-5048.20140617
Citation: SUN Jialin, PANG Lei, WANG Shuai, MENG Xiansheng, BAO Yongrui. Establishment of myocardial ischemia-reperfusion injury model based on microfluidic chip[J]. Journal of China Pharmaceutical University, 2014, 45(6): 710-714. DOI: 10.11665/j.issn.1000-5048.20140617

Establishment of myocardial ischemia-reperfusion injury model based on microfluidic chip

More Information
  • This study was aimed to establish the ischemia-reperfusion(I/R)myocardial cells injury model using microfluidic technology in vitro. This model was fast and efficient to be used for drug screening especially in the field of cardiovascular drug. In the present study, we firstly made a fan-shaped microfluidic chip using soft lithography technology and molding technology, then the myocardial cells were cultured in this chips. Then the cells were exposed to ischemic tyrode′s reagents to mimic the I/R injury followed by the cell viability analysis. The morphology and the content of damage index were analyzed by Wright-Giemsa dye and ELISA kit, respectively. Finally, puerarin was used to evaluate the efficiency of this model since Compared with the control group, the cell viability of myocardial cells cultured in this chip was up to 98% in the chip. Also, there was not significant diffe-rence of myocyte apoptosis and damage index′ content between cells cultured in normal condition and that cultured in chip. Furthermore, puerarin treatment ameliorated the myocyte apoptosis, and the content of damage index induced by the I/R injury. Therefore, we successfully established the injury model based on microfluidic technology in vitro, providing novel idea and method for drug screening in the field of cardiovascular repair by microfluidic technology.
  • [1]
    Xin YH,Guo X.In vivo animal models of mycardial ischemia[J].Adv Cardiovasc Dis(心血管病学进展),2009,30:38-41.
    [2]
    Kawada T,Yamazaki T,Akiyama T,et al.Vagal stimulation suppresses ischemia-induced myocardial interstitial myoglobin release[J].Life Sci,2010,83:490-495.
    [3]
    Khanal G,Chung K,Solis-Wever X,et al.Ischemia/reperfusion injury of primary porcine cardiomyocytes in a low-shear microfluidic culture and analysis device[J].Analyst,2011,136(17):3 519-3 526.
    [4]
    Zhang NJ,Zhang TT,Liu ZX,et al.Establishmen of ischemia/reperfusion injury model of mycardial cell in vitro[J].Sichuan J Zool(四川动物),2009,28(3):440-443.
    [5]
    Mehling N,Tay S.Microfluidic cell culture[J].Curr Opinion Biotechnol,2014,25:95-102.
    [6]
    Kim P,Kwon KW,Park MC,et al.Soft lithography for microfluidics:a review[J].Biochip J,2008,2(1):1-11.
    [7]
    Friend J, Yeo L. Fabrication of microfluidic devices using polydimethysiloxane[J].Biomicrofluidics,2010,4(2):1-5.
    [8]
    Yu YP,Zhou CL,Fu WF,et al.Effects of curcumin on ischemia/reperfusion induced apoptosis of H9c2 myocardial cells and the expression of glycogen synthase kinase-3 and its phosphorylation[J].Chin J Integr Tradif Chin West Med(中国中西医结合杂志),2013,33(2):240-243.
    [9]
    Cheng LL,Wu SH,Li ZL,et al.Improving and evaluating the method of establishing rat models of acute myocardial eschemia reperfusion[J].Chin J Lab Diagn(中国实验诊断学),2010,14(8):1 163-1 165.
    [10]
    Lu DX, Wu HY, Lu DR, et al. Important issues and relative approaches in myocardial ischemic reperfusion[J].Chin J Exp Tradit Med Formulae(中国实验方剂学),2011,17(12):245-248.
    [11]
    Ma LD,Wang YT,Meng XS,et al.A cell migration model based on microfluidics and its application for the baicalin pharmacodynamics research[J].J China Pharm Univ(中国药科大学学报),2014,45(3):352-357.
  • Related Articles

    [1]HOU Kai, TAN Haoyu, LIU Jing, LI Yunman. Advance of novel target strategies participating in myocardial ischemia reperfusion injury[J]. Journal of China Pharmaceutical University, 2022, 53(2): 164-170. DOI: 10.11665/j.issn.1000-5048.20220205
    [2]REN Yi, SU Mei, ZHENG Jing, QIN Yinlin, CHEN Tao, JI Hui. Protective effects of Naomaili granules on cerebral ischemia-reperfusion in rats and its mechanism[J]. Journal of China Pharmaceutical University, 2015, 46(1): 100-104. DOI: 10.11665/j.issn.1000-5048.20150115
    [3]Effect of danshensu on myocardial energy metabolism in isolated ischemia-reperfusion rat hearts[J]. Journal of China Pharmaceutical University, 2010, 41(3): 278-282.
    [4]Influence of Puerarin on Endogenous NOS Inhibitor of Human Umbilical Vein Endothelial Cells Cultured with Oxidized Low Density Lipoprotein[J]. Journal of China Pharmaceutical University, 2004, (4): 63-66.
    [5]Effects of Surfacant on the Dissolution of Puerarin Solid Dispersion[J]. Journal of China Pharmaceutical University, 2004, (4): 25-27.
    [6]Inhibition of Puerarin on the H_2O_2-induced Apoptosis of Smooth Muscle Cells[J]. Journal of China Pharmaceutical University, 2002, (3): 75-78.
    [7]Determination of Purearinin Dog Plasma after Oral Administration of Puerarin lobata Recipe by HPLC[J]. Journal of China Pharmaceutical University, 2001, (2): 47-49.
    [8]Preparation and Bio activity of Puerarin Derivatives[J]. Journal of China Pharmaceutical University, 1999, (2): 3-7.
    [9]Studies on Lowing IOP Effect of Puerarin Eyedrops[J]. Journal of China Pharmaceutical University, 1998, (5): 67-69.
    [10]Studies on Pharmacokinetics of Puerarin Eyedrops[J]. Journal of China Pharmaceutical University, 1998, (3): 71-74.

Catalog

    Article views (1538) PDF downloads (1191) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return